ERIN HOLLEMAN: Open Payments
NPI 1801021696 · MALVERN, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$196 in 10 payments from 5 companies in 2025. Trend: 2023 $403 · 2024 $180 · 2025 $196
Food & beverage: $196
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $105 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Lundbeck LLC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: Auvelity, REXULTI, CAPLYTA, AUSTEDO XR.
Industry payments across AR — which companies pay providers there.
